Pituitary Cancer Market is trending with CAGR of 9.4% by 2023
Market Research Future recently announced the addition of a new research study to its comprehensive collection of research reports. The report Global Pituitary Cancer Market 2018 offers vital insights on every market segment in terms of market size analysis for automotive hybrid fuel sensors across the different regions.
Global Pituitary Cancer Market - Overview
Pituitary gland is a very small gland responsible for producing hormones which regulates critical body organs and glands. It is located behind the eyes and below the front side of the brain. It is a very rare type of cancer.
Only a few hundred pituitary cancers have ever been recorded till the date. Most of those were diagnosed in older people. Most pituitary tumors are noncancerous (benign) in nature. According to the American Cancer Society, few of the 10,000 tumors projected to be diagnosed in 2016 will turn out to be cancerous.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1657
The pituitary gland is connected directly to part of the brain called the hypothalamus. This provides a key link between the brain and the endocrine system, a collection of glands in the body that make hormones. The hypothalamus releases hormones into tiny blood vessels connected to the pituitary gland. These then cause the pituitary gland to make its own hormones.
Benign tumors account for about 30 to 40 percent of all pituitary tumors, according to the American Brain Tumor Association. They are most common in young, reproductive-age women and men in their 40s and 50s.
Many different kinds of drugs can be used to treat pituitary cancer such as Pasireotide (Signifor) is a somatostatin analogs, Cabergoline (Dostinex) and bromocriptine (Parlodel) are most commonly used as dopamine agonists. Pegvisomant (Somavert) is the novel drug under the class of growth hormone antagonists.
The corticotropin (ACTH)-secreting tumors drugs such as Cyproheptadine (Periactin) is an antihistamine drug that can suppress ACTH production in some of these tumors. Mifepristone (Korlym) is a type of drug called a cortisol receptor blocker. It limits the effects of cortisol on other tissues in the body.
The global pituitary cancer market is growing exponentially owing to the increasing prevalence of cancerous tumors and hormonal imbalances these factor are contributing to the growth of the market. Globally the market for Pituitary cancer is expected to grow at the rate of about 6.8% from 2016 to 2022.
Global Pituitary Cancer Market - Key players
Trinity Biotech (Ireland)
Salzman International (U.S.)
Genentech, Inc. (U.S.)
Sigma-Aldrich Co. LLC (U.S.)
Varian Medical Systems, Inc. (U.S.)
Elekta AB (Sweden)
Accuray Incorporated (U.S.)
Ion Beam Applications (Belgium)
Nordion, Inc. (Canada)
Global Pituitary Cancer Market - Regional Analysis
Global pituitary cancer market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa.
On regional, North America has the largest market for the pituitary cancer. The major factor for the growth of this market in North America is robust research & development practices and growing advancements in the field of neurology. Europe has a runner-up market for pituitary cancer. Adoption of sedentary lifestyle and increase in workload is the major factor for the causing pituitary cancer to the patient in Europe.
Asia Pacific is the fastest growing market and is expecting to take Europe position for pituitary cancer market. Increasing work load and a huge development in healthcare sector has boosted this market in Asia Pacific region.
GET REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/pituitary-cancer-market-1657
Major Points form Table of Content of Global Pituitary Cancer Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Pituitary Cancer Market, By Type
Chapter 7. Global Pituitary Cancer Market, By Treatment
Chapter 8 Global Pituitary Cancer Market, By End User
Chapter 9. Global Pituitary Cancer Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Global Pituitary Cancer Market - Overview
Pituitary gland is a very small gland responsible for producing hormones which regulates critical body organs and glands. It is located behind the eyes and below the front side of the brain. It is a very rare type of cancer.
Only a few hundred pituitary cancers have ever been recorded till the date. Most of those were diagnosed in older people. Most pituitary tumors are noncancerous (benign) in nature. According to the American Cancer Society, few of the 10,000 tumors projected to be diagnosed in 2016 will turn out to be cancerous.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1657
The pituitary gland is connected directly to part of the brain called the hypothalamus. This provides a key link between the brain and the endocrine system, a collection of glands in the body that make hormones. The hypothalamus releases hormones into tiny blood vessels connected to the pituitary gland. These then cause the pituitary gland to make its own hormones.
Benign tumors account for about 30 to 40 percent of all pituitary tumors, according to the American Brain Tumor Association. They are most common in young, reproductive-age women and men in their 40s and 50s.
Many different kinds of drugs can be used to treat pituitary cancer such as Pasireotide (Signifor) is a somatostatin analogs, Cabergoline (Dostinex) and bromocriptine (Parlodel) are most commonly used as dopamine agonists. Pegvisomant (Somavert) is the novel drug under the class of growth hormone antagonists.
The corticotropin (ACTH)-secreting tumors drugs such as Cyproheptadine (Periactin) is an antihistamine drug that can suppress ACTH production in some of these tumors. Mifepristone (Korlym) is a type of drug called a cortisol receptor blocker. It limits the effects of cortisol on other tissues in the body.
The global pituitary cancer market is growing exponentially owing to the increasing prevalence of cancerous tumors and hormonal imbalances these factor are contributing to the growth of the market. Globally the market for Pituitary cancer is expected to grow at the rate of about 6.8% from 2016 to 2022.
Global Pituitary Cancer Market - Key players
Trinity Biotech (Ireland)
Salzman International (U.S.)
Genentech, Inc. (U.S.)
Sigma-Aldrich Co. LLC (U.S.)
Varian Medical Systems, Inc. (U.S.)
Elekta AB (Sweden)
Accuray Incorporated (U.S.)
Ion Beam Applications (Belgium)
Nordion, Inc. (Canada)
Global Pituitary Cancer Market - Regional Analysis
Global pituitary cancer market, on the basis of regions is divided into North America, Europe, Asia Pacific and Middle East and Africa.
On regional, North America has the largest market for the pituitary cancer. The major factor for the growth of this market in North America is robust research & development practices and growing advancements in the field of neurology. Europe has a runner-up market for pituitary cancer. Adoption of sedentary lifestyle and increase in workload is the major factor for the causing pituitary cancer to the patient in Europe.
Asia Pacific is the fastest growing market and is expecting to take Europe position for pituitary cancer market. Increasing work load and a huge development in healthcare sector has boosted this market in Asia Pacific region.
GET REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/pituitary-cancer-market-1657
Major Points form Table of Content of Global Pituitary Cancer Market
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Pituitary Cancer Market, By Type
Chapter 7. Global Pituitary Cancer Market, By Treatment
Chapter 8 Global Pituitary Cancer Market, By End User
Chapter 9. Global Pituitary Cancer Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com